Actuate Therapeutics, Inc. (ACTU) vs Passage Bio, Inc. (PASG)
Actuate Therapeutics, Inc. and Passage Bio, Inc. are both Biotechnology companies. Actuate Therapeutics, Inc. and Passage Bio, Inc. are of similar size ($15.9M and $15.5M). Across the 8 metrics below, Actuate Therapeutics, Inc. leads on 6 and Passage Bio, Inc. on 2.
Valuation
Profitability
| Metric | ACTU | PASG | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 0.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | 2,457.65% | (169.09%) | (57.72%) |
| Return on assets | (336.18%) | (69.20%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack